Cargando…
Hypoxia imaging with [(18)F]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning
BACKGROUND: Radical chemoradiotherapy is the primary treatment for head and neck cancers in many hospitals. Tumour hypoxia causes radiotherapy resistance and is an indicator of poor prognosis for patients. Identifying hypoxia to select patients for intensified or hypoxia-modified treatment regimens...
Autores principales: | Betts, Helen M., O’Connor, Richard A., Christian, Judith A., Vinayakamoorthy, Vidhiya, Foweraker, Karen, Pascoe, Abigail C., Perkins, Alan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282932/ https://www.ncbi.nlm.nih.gov/pubmed/30371605 http://dx.doi.org/10.1097/MNM.0000000000000933 |
Ejemplares similares
-
Evaluation of tumour hypoxia during radiotherapy using [(18)F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
por: Zegers, Catharina M. L., et al.
Publicado: (2016) -
Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer
por: Sanduleanu, Sebastian, et al.
Publicado: (2020) -
[(18)F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials
por: Sanduleanu, Sebastian, et al.
Publicado: (2020) -
Repeatability of hypoxia PET imaging using [(18)F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial
por: Zegers, Catharina M. L., et al.
Publicado: (2015) -
Pharmacokinetic modeling of a novel hypoxia PET tracer [(18)F]HX4 in patients with non-small cell lung cancer
por: Verwer, E. E., et al.
Publicado: (2016)